Dehydro silodosin

• Description :

  Dehydro silodosin (KMD-3241) is a selective α1A-adrenoceptor antagonist used in the study of benign prostatic hyperplasia[1].

• Product Name Alternative :

  KMD-3241

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Adrenergic Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Cancer

• Smiles :

  OCCCN1C2=C(C(N)=O)C=C(C[C@@H](C)NCCOC3=C(C=CC=C3)OCC(F)(F)F)C=C2C=C1

• Molecular Formula :

  C25H30F3N3O4

• Molecular Weight :

  493.52

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Yoshida M, et al. Silodosin, a novel selective α1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia. Expert opinion on investigational drugs, 2007, 16 (12) : 1955-1965.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound2

• Clinical Information :

  No Development Reported

• CAS Number :

  [175870-21-0]